Compare SELLAS Life Sciences Group Inc. Common Stock (SLS) vs Victoria's Secret & Co (VSXY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SELLAS Life Sciences Group Inc. Common Stock vs Victoria's Secret & Co — how do they compare? SELLAS Life Sciences Group Inc. Common Stock trades at $11.65 (market cap $2.27B), while Victoria's Secret & Co trades at $82.87 (market cap $6.91B). The key difference: Victoria's Secret & Co is far larger — about 3× SELLAS Life Sciences Group Inc. Common Stock's market cap, and SELLAS Life Sciences Group Inc. Common Stock is more actively traded (4,179,659 versus 1,346,928). Which is the better fit depends on your goals.
| SLS | VSXY | |
|---|---|---|
Market Cap | $2.27B | $6.91B |
Volume | 4,179,659 | 1,346,928 |
Sector | Health | Consumer Cyclical |
52-Week High | $15.46 | $99.97 |
52-Week Low | $1.39 | $28.25 |
Enterprise Value | $2.14B | $9.29B |
Typical Hold Time | — | 34 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Victoria's Secret (VSXY) trades at $86.61, up 0.96% with strong technical momentum and bullish moving average signals. The company demonstrates improving fundamentals with three consecutive quarterly earnings beats and a projected 2026 net income rebound to $378M. Recent news highlights brand momentum through fashion show expansion and omnichannel growth, though valuation remains elevated at P/E 19.33.
The outlook appears positive with 60% analyst buy ratings and $86.80 consensus target, but risks include rich valuation, rising costs, and competitive pressures. Earnings growth acceleration and international expansion provide catalysts, while margin sustainability and consumer demand volatility present challenges for sustained shareholder returns.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About SELLAS Life Sciences Group Inc. Common Stock
SELLAS Life Sciences is a late-stage clinical biopharmaceutical company developing therapies for cancer. Its programs include a WT1-targeting cancer immunotherapy and a selective CDK9 inhibitor.
Read more on SLS →About Victoria's Secret & Co
Victoria's Secret & Co is a specialty retailer of lingerie, pajamas, and beauty products with prestige fragrances and body care. It serves customers at its Lingerie and Beauty stores around the globe and online enabling them to shop the brand anywhere and anytime.
Read more on VSXY →
